CRISAFULLI, Ernesto
 Distribuzione geografica
Continente #
NA - Nord America 6.157
EU - Europa 4.893
AS - Asia 3.937
SA - Sud America 629
Continente sconosciuto - Info sul continente non disponibili 354
AF - Africa 100
OC - Oceania 8
Totale 16.078
Nazione #
US - Stati Uniti d'America 6.026
RU - Federazione Russa 2.276
SG - Singapore 1.841
IT - Italia 1.049
CN - Cina 734
BR - Brasile 496
HK - Hong Kong 450
VN - Vietnam 383
FR - Francia 375
IE - Irlanda 310
DE - Germania 257
GB - Regno Unito 141
SE - Svezia 129
KR - Corea 128
BD - Bangladesh 107
NL - Olanda 98
FI - Finlandia 73
IN - India 67
AR - Argentina 66
CA - Canada 64
ID - Indonesia 34
IQ - Iraq 31
JP - Giappone 31
PL - Polonia 30
ES - Italia 29
MX - Messico 29
TR - Turchia 24
BE - Belgio 23
ZA - Sudafrica 20
BJ - Benin 19
UA - Ucraina 18
EC - Ecuador 17
NG - Nigeria 17
CL - Cile 15
PK - Pakistan 15
LT - Lituania 12
SA - Arabia Saudita 12
CO - Colombia 11
AT - Austria 10
EU - Europa 10
MY - Malesia 10
PH - Filippine 10
TG - Togo 10
UZ - Uzbekistan 10
JO - Giordania 9
VE - Venezuela 9
AE - Emirati Arabi Uniti 7
JM - Giamaica 7
KE - Kenya 7
PY - Paraguay 7
CR - Costa Rica 6
CZ - Repubblica Ceca 6
MA - Marocco 6
AL - Albania 5
AU - Australia 5
DO - Repubblica Dominicana 5
DZ - Algeria 5
EG - Egitto 5
LV - Lettonia 5
RO - Romania 5
BG - Bulgaria 4
BH - Bahrain 4
BY - Bielorussia 4
GT - Guatemala 4
HU - Ungheria 4
KZ - Kazakistan 4
LB - Libano 4
NO - Norvegia 4
NP - Nepal 4
PT - Portogallo 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
AZ - Azerbaigian 3
BZ - Belize 3
CH - Svizzera 3
HN - Honduras 3
HR - Croazia 3
IR - Iran 3
MT - Malta 3
SI - Slovenia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BO - Bolivia 2
DK - Danimarca 2
IL - Israele 2
MG - Madagascar 2
NC - Nuova Caledonia 2
RS - Serbia 2
SN - Senegal 2
SY - Repubblica araba siriana 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BS - Bahamas 1
CU - Cuba 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
EE - Estonia 1
ET - Etiopia 1
Totale 15.721
Città #
Dallas 1.226
Singapore 871
Ashburn 869
Moscow 761
San Jose 749
Chandler 476
Hong Kong 447
Council Bluffs 322
Dublin 305
Verona 237
The Dalles 193
Jacksonville 185
Ho Chi Minh City 131
Beijing 119
Lawrence 108
Princeton 108
Los Angeles 105
Sindelfingen 100
New York 87
Seattle 87
Wilmington 84
Hanoi 75
Redondo Beach 70
Buffalo 64
Rome 57
Santa Clara 54
São Paulo 51
Milan 49
Columbus 44
Boardman 40
Munich 39
London 37
Redmond 35
Frankfurt am Main 34
Helsinki 34
Tokyo 29
Bologna 27
Xi'an 26
Ann Arbor 25
Turku 25
Warsaw 25
Falkenstein 24
Norwalk 24
Southend 24
Haiphong 23
Orem 23
Tianjin 21
Chicago 20
Cotonou 19
Amsterdam 18
Montreal 18
Nuremberg 18
Abuja 17
Brussels 17
Da Nang 17
Denver 17
Guangzhou 17
Phoenix 17
San Francisco 17
Atlanta 16
Brooklyn 16
Dongguan 16
Toronto 16
Chennai 15
Paris 15
Rio de Janeiro 15
Turin 15
Jinan 14
Lappeenranta 14
Stockholm 14
Poplar 13
City of London 12
Falls Church 12
Mexico City 12
Naples 12
Baghdad 11
Kent 11
Ankara 10
Curitiba 10
Jakarta 10
Lomé 10
Mumbai 10
Nanjing 10
New Delhi 10
Amman 9
Bari 9
Biên Hòa 9
Boston 9
Changsha 9
Genoa 9
Hangzhou 9
Houston 9
Johannesburg 9
Trento 9
Belo Horizonte 8
Fairfield 8
Manchester 8
Seoul 8
Tashkent 8
Trieste 8
Totale 9.218
Nome #
Polmonite interstiziale con caratteristiche autoimmuni (IPAF) Interstitial pneumonia with autoimmune features (IPAF 714
Glucocorticoid Treatment in Severe COPD Exacerbations: Biological Rationale, Clinical Effects, and Practical Advice 361
Persistence of fatigue in the absence of pathophysiological mechanisms in some patients more than 2 years after the original SARS-CoV-2 infection 299
Role of Non-Invasive Ventilation in Elderly Patients: Therapeutic Opportunity or Medical Futility? An Updated Narrative Review 267
Nervous system: subclinical target of SARS-CoV-2 infection 186
Asthmatic patients in COVID-19 outbreak: Few cases despite many cases 183
Exercise prehabilitation in lung cancer: Getting stronger to recover faster 182
Asthma in a large COVID-19 cohort: Prevalence, features, and determinants of COVID-19 disease severity 181
Neurological symptoms and axonal damage in COVID-19 survivors: are there sequelae? 179
Chronic fatigue syndrome: an emerging sequela in COVID-19 survivors? 178
Serology study after BTN162b2 vaccination in participants previously infected with SARS-CoV-2 in two different waves versus naïve 178
Six-minute walk distance in healthy subjects: reference standards from a general population sample 165
Cytomegalovirus-Induced Gastrointestinal Bleeding and Pancreatitis Complicating Severe Covid-19 Pneumonia: A Paradigmatic Case 159
Acute exacerbations of COPD: Risk factors for failure and relapse 157
Importance of Cardiopulmonary Exercise Testing amongst Subjects Recovering from COVID-19 157
COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian survey 152
A shadow in the GOLD ABCD classification system: measurement of perception of symptoms in COPD 152
Bone Mineral Density in Mountain, Road Cyclists and Untrained Controls: Exercise, Diet and Hormones 151
Impact of the Visceral Adipose Tissue on Bone Quality in Patients with Untreated mild-to-severe Obstructive Sleep Apnoea 151
A pulmonary infection by Actinomyces odontolyticus and Veillonella atypica in an immunocompetent patient with dental caries 150
Residual Lung Function Impairment Is Associated with Hyperventilation in Patients Recovered from Hospitalised COVID-19: A Cross-Sectional Study 146
Impact of sex on circulating leukocytes composition in COPD patients 144
Mepolizumab 100 mg in severe asthmatic patients with EGPA in remission phase 140
Efficacy of temporary positive expiratory pressure (TPEP) in patients with lung diseases and chronic mucus hypersecretion. The UNIKO® project: a multicentre randomized controlled trial 133
Aerobic Intermittent Hypoxic Training Is Not Beneficial for Maximal Oxygen Uptake and Performance: A Systematic Review and Meta-Analysis 131
Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: results from the SIMI-COVID-19 study of the Italian Society of Internal Medicine (SIMI) 130
Metabolic-associated fatty liver disease and liver fibrosis scores as COVID-19 outcome predictors: a machine-learning application 128
Beyond diagnosis: a narrative review of the evolving therapeutic role of medical thoracoscopy in the management of pleural diseases 128
A High Degree of Dyspnea Is Associated With a Poor Maximum Exercise Capacity in Subjects With COPD With the Same Severity of Air-Flow Obstruction 128
Baseline Exercise Tolerance and Perceived Dyspnea to Identify the Ideal Candidate to Pulmonary Rehabilitation: A Risk Chart in COPD Patients 127
Persisting exercise ventilatory inefficiency in subjects recovering from COVID-19. Longitudinal data analysis 34 months post-discharge 126
Circulating eosinophil levels and lung function decline in stable chronic obstructive pulmonary disease: a retrospective longitudinal study 126
Age is a determinant of short-term mortality in patients hospitalized for an acute exacerbation of COPD 125
Short-term efficacy of upper-extremity exercise training in patients with chronic airway obstruction: A systematic review 123
Are interstitial lung abnormalities associated with COPD? A nested case–control study 123
Assessment of severity of ICU-acquired pneumonia and association with etiology 123
Asymptomatic peripheral artery disease can limit maximal exercise capacity in chronic obstructive pulmonary disease patients regardless of airflow obstruction and lung hyperinflation 122
Exercise ventilatory inefficiency may be a relevant CPET-feature in COVID-19 survivors 121
The Caliber of Segmental and Subsegmental Vessels in COVID-19 Pneumonia Is Enlarged: A Distinctive Feature in Comparison with Other Forms of Inflammatory and Thromboembolic Diseases 120
Innate immune reprogramming in circulating neutrophils of COPD patients 120
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 118
A Practical Approach to Pneumothorax Management 117
Anthropometry in Special and Selective Conditions and Circumstances: Anthropometry as Measure of Risk in COPD Patients 117
Relevance of Smoking Habit in Severe Asthma Patients: Evidence from the Severe Asthma Network in Italy (SANI) Registry 116
Activity and analysis of costs in a dedicated weaning centre 116
Association between persistent dyspnea and psychological distress in COVID-19 survivors. A cross-sectional evaluation at 11 months after hospitalization 112
Feasibility and effectiveness of an educational program in Italian COPD patients undergoing rehabilitation 110
Systemic Inflammatory Response and Outcomes in Community-Acquired Pneumonia Patients Categorized According to the Smoking Habit or Presence of Chronic Obstructive Pulmonary Disease 110
Clinical risk scores for the early prediction of severe outcomes in patients hospitalized for COVID-19 110
C-reactive protein at discharge, diabetes mellitus and ≥1 hospitalization during previous year predict early readmission in patients with acute exacerbation of chronic obstructive pulmonary disease 109
Association Between Rome Classification Among Hospitalized Patients With COPD Exacerbations and Short-Term and Intermediate-Term Outcomes 105
Endotracheal tubes for critically ill patients: An in vivo analysis of associated tracheal injury , mucociliary clearance, and sealing effi cacy 104
Effect of α1 Antitrypsin Deficiency on Lung Volume Decline in Severe Asthmatic Patients Undergoing Biologic Therapy 102
Exploring the efficacy and advancements of medical pleurodesis: a comprehensive review of current research 101
Management of severe acute exacerbations of COPD: an updated narrative review 101
Do Patients with Bronchiectasis Have an Increased Risk of Developing Lung Cancer? A Systematic Review 100
Aetiological diagnosis in new adult outpatients with bronchiectasis:role of predictors derived from real life experience 98
Factors associated with risk of death in hospitalized patients for exacerbation of chronic obstructive pulmonary disease: an updated scoping review 96
Relationships between emphysema and airways metrics at High-Resolution Computed Tomography (HRCT) and ventilatory response to exercise in mild to moderate COPD patients 96
Effects of unsupported upper extremity exercise training in patients with COPD: A randomized clinical trial 95
Reducing Hospital Readmissions in Chronic Obstructive Pulmonary Disease Patients: Current Treatments and Preventive Strategies 95
Endobronchial ultrasound: a pictorial essay 94
Cost-effectiveness of NIV applied to chronic respiratory failure 93
Cough, a vital reflex. mechanisms, determinants and measurements 93
Effectiveness of erdosteine in elderly patients with bronchiectasis and hypersecretion: A 15-day, prospective, parallel, open-label, pilot study 93
Prevalence of Depression in Sarcoidosis: a comparison with asthmatic and healthy controls 92
COPD and the metabolic syndrome: An intriguing association 92
Effects of a walking aid in COPD patients receiving oxygen therapy 91
Inhaled corticosteroids do not influence the early inflammatory response and clinical presentation of hospitalized subjects with COPD exacerbation 91
Endoscopic Technologies for Peripheral Pulmonary Lesions: From Diagnosis to Therapy 90
Autonomic nervous system alterations in patients with mild-to-moderate asthma: do not forget airflow obstruction! a lesson from COPD 90
Rehabilitation and supportive therapy in elderly patients with chronic obstructive pulmonary disease 90
Pneumonic versus Nonpneumonic Exacerbations of Chronic Obstructive Pulmonary Disease 90
Use of non-invasive respiratory supports in high-intensity internal medicine setting during the first two waves of the COVID-19 pandemic emergency in Italy: a multicenter, real-life experience 90
Transthoracic Echocardiography and Chest Computed Tomography Arteriography in Patients with Acute Pulmonary Embolism: A Two-Year Follow-Up Study 89
The Role of Medical Thoracoscopy with Talc Poudrage in Spontaneous, Iatrogenic, and Traumatic Pneumothorax: A Prolonged Experience of a Tertiary Care Center 88
Reply to "Mepolizumab in patients with eosinophilic granulomatosis with polyangiitis in remission: What is the right dose?" 88
Efficacy of standard rehabilitation in COPD outpatients with comorbidities 88
Inhaled beclometasone dipropionate/formoterol fumarate extrafine fixed combination for the treatment of asthma 88
Impact of bronchiectasis on outcomes of hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease: A propensity matched analysis 87
Rehabilitation in COPD patients admitted for exacerbation 87
Clinical variables predicting the risk of a hospital stay for longer than 7 days in patients with severe acute exacerbations of chronic obstructive pulmonary disease: a prospective study 86
Long-term weight loss and maintenance in morbidly obese individuals with obstructive sleep apnea 86
Home-centred physical fitness programme in morbidly obese individuals: A randomized controlled trial 85
Learning impact of education during pulmonary rehabilitation program. An observational short-term cohort study 85
Minimum Clinically Important Difference in 30-s Sit-to-Stand Test After Pulmonary Rehabilitation in Subjects With COPD 84
Respiratory muscles training in COPD patients 84
Energy expenditure at rest and during walking in patients with chronic respiratory failure: a prospective two-phase case-control study 84
Systemic inflammatory pattern of patients with community-acquired pneumonia with and without COPD 83
Predicting walking-induced oxygen desaturations in COPD patients: A statistical model 83
Home non-invasive mechanical ventilation and long-term oxygen therapy in stable hypercapnic chronic obstructive pulmonary disease patients: Comparison of costs 82
Measures of dyspnea in pulmonary rehabilitation 82
Effects of beclomethasone/formoterol fixed combination on lung hyperinflation and dyspnea in COPD patients 82
Impact of the visceral adipose tissue on bone quality in patients with untreated mild-to-severe obstructive sleep apnea 81
COPD 2017: A Year in Review 81
Pleuritis with pleural effusion due to a Bacillus megaterium infection 80
Prevalence of Small-Airway Dysfunction among COPD Patients with Different GOLD Stages and Its Role in the Impact of Disease 80
The role of the microbiome in childhood asthma 80
Predicting poor prognosis in COPD patients: Looking for a lamp lit in the darkness of the night 79
Efficacy and Safety of Reparixin in Patients with Severe COVID-19 Pneumonia: A Phase 3, Randomized, Double-Blind Placebo-Controlled Study 78
Totale 12.463
Categoria #
all - tutte 62.043
article - articoli 60.234
book - libri 0
conference - conferenze 435
curatela - curatele 0
other - altro 270
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.104
Totale 124.086


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022563 0 142 4 22 13 20 6 74 30 26 88 138
2022/20231.583 132 115 230 246 130 380 12 104 140 21 42 31
2023/20241.002 47 73 139 141 63 126 48 92 10 40 127 96
2024/20252.767 196 103 79 420 131 126 108 152 431 172 265 584
2025/20269.202 586 365 1.434 1.334 2.026 540 777 548 685 436 199 272
2026/2027402 132 270 0 0 0 0 0 0 0 0 0 0
Totale 16.078